Skip to main content
Melvin Spigelman, MD, Oncology, Bronx, NY

Melvin Kalman Spigelman MD


President & CEO, Global Alliance for TB Drug Development, NY, NY 10005

Join to View Full Profile
  • 4655 Douglas AveBronx, NY 10471

  • Phone+1 718-432-7572

  • Fax+1 718-432-7572

Dr. Spigelman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Medical Oncology, 1977 - 1980
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Public Health and General Preventive Medicine, 1977 - 1979
  • Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
    Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1974 - 1977
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1974

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1976 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology
  • General Preventive Medicine
    American Board of Preventive Medicine General Preventive Medicine

Publications & Presentations

PubMed

Press Mentions

  • New TB Drug Regimen Controls Resistant Disease in 9 of 10 Cases: Study
    New TB Drug Regimen Controls Resistant Disease in 9 of 10 Cases: StudyMarch 4th, 2020

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: